Markets open

Cardinal Health, Inc.

CAH · NYSE

Symbol: CAH
Type: Stock
Sector: Health Care
Industry: Other Pharmaceuticals
Country: North America
Exchange: NYSE

Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day.

Key Issues

Bullish view

Zacks says Cardinal has the right combination of two key ingredients for a likely beat, while Wall Street expects earnings growth in the upcoming report.

Bearish view

The supplied evidence contains expectations rather than reported results, so there is no confirmed beat, guidance increase, or operating detail to validate the bullish setup.

Analyst Consensus

See all

Buy

15 analysts

$238

Current

—

Low

$257

Average

—

High

Average target implies +7.97% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Cencora, Inc.COR · NYSE

$318.043.84%

Boston Scientific CorporationBSX · NYSE$48.102.02%

The Cigna GroupCI · NYSE$271.101.08%

Regeneron Pharmaceuticals, Inc.REGN · Nasdaq$775.291.92%

$237.56+$4.021.72%

As of: Aug 5, 6:11 PM

Prev Close: $233.55
Market Cap: $55.64B
Open: —
Trailing P/E: —
Day Range: $239.18 - $235.21
52W Range: $243.21 - $137.75
Forward P/E: —
EPS: —
Volume: 882.15K
Dividend Yield: —

About Cardinal Health, Inc.

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and provides medical products and related supply-chain services. Its Pharmaceutical and Specialty Solutions business is the larger revenue engine, serving pharmacies, hospitals, healthcare providers, and pharmaceutical manufacturers; its medical-products business serves hospitals, ambulatory facilities, laboratories, and other providers. The company earns revenue primarily through product distribution and related services. Cardinal operates at substantial scale: fiscal 2025 revenue is $222.6 billion and net income is $1.6 billion, compared with $226.8 billion of revenue and $0.9 billion of net income in fiscal 2024.

Notable Price Movement

Aug 3-7$233.551.53%
Cardinal Health rose $1.04, or 0.45%, over the week, from $232.51 to $233.55. The move was concentrated on Monday, when shares gained 2.42% to $235.60 after Zacks highlighted the stock’s outperformance and ahead-of-report earnings expectations. Shares then gave back $2.05, or 0.87%, on Tuesday, leaving only a modest net advance. Zacks also described Cardinal as a strong value stock, but the supplied evidence identifies no earnings release, guidance change, contract, or other company-specific event during the period. The stock therefore moved higher amid pre-earnings positioning and favorable value commentary, with the reversal indicating limited follow-through rather than a sustained breakout.